2-(3-(6-Hydroxynaphthalen-2-yl)propiolamido)cyclohex-1-enecarboxylic acid

ID: ALA3298702

Chembl Id: CHEMBL3298702

PubChem CID: 90645402

Max Phase: Preclinical

Molecular Formula: C20H17NO4

Molecular Weight: 335.36

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  O=C(C#Cc1ccc2cc(O)ccc2c1)NC1=C(C(=O)O)CCCC1

Standard InChI:  InChI=1S/C20H17NO4/c22-16-9-8-14-11-13(5-7-15(14)12-16)6-10-19(23)21-18-4-2-1-3-17(18)20(24)25/h5,7-9,11-12,22H,1-4H2,(H,21,23)(H,24,25)

Standard InChI Key:  HRENAONSNVROBZ-UHFFFAOYSA-N

Associated Targets(Human)

HCAR2 Tclin Hydroxycarboxylic acid receptor 2 (1903 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HCAR3 Tchem HM74 nicotinic acid GPCR (353 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HCAR1 Tchem G-protein coupled receptor 81 (382 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 335.36Molecular Weight (Monoisotopic): 335.1158AlogP: 2.93#Rotatable Bonds: 2
Polar Surface Area: 86.63Molecular Species: ACIDHBA: 3HBD: 3
#RO5 Violations: HBA (Lipinski): 5HBD (Lipinski): 3#RO5 Violations (Lipinski):
CX Acidic pKa: 2.85CX Basic pKa: CX LogP: 3.16CX LogD: -0.33
Aromatic Rings: 2Heavy Atoms: 25QED Weighted: 0.74Np Likeness Score: 0.16

References

1. Bobileva O, Bokaldere R, Gailite V, Kaula I, Ikaunieks M, Duburs G, Petrovska R, Mandrika I, Klovins J, Loza E..  (2014)  Synthesis and evaluation of (E)-2-(acrylamido)cyclohex-1-enecarboxylic acid derivatives as HCA1, HCA2, and HCA3 receptor agonists.,  22  (14): [PMID:24864041] [10.1016/j.bmc.2014.05.011]

Source